Cipla Ltd.
BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1438.75
-2.95 (-0.20%) Cipla informs about press release
Date: 28-01-2019Cipla has informed about press release titled ‘Cipla receives final approval for generic version of Pfizers Depo-Provera (Medroxyprogesterone Injectable, 150mg/mL)’.
The above information is a part of company’s filings submitted to BSE.